Exhibiting at VIV Asia 2025

Pharmaceutical And Veterinary Material JSC (HANVET), based in Hanoi, Vietnam, is a pioneering manufacturer and exporter of veterinary medicines, vaccines, and nutritional supplements for livestock and poultry. Established in 1956, HANVET is one of Vietnam’s oldest and most respected animal health companies, known for its comprehensive product portfolio, domestic leadership, and growing global footprint.

Core Business

HANVET’s core business focuses on the research, development, production, and distribution of pharmaceutical and biological products for animal health. With an integrated approach to animal disease prevention and treatment, HANVET supports Vietnam’s growing livestock and poultry industries while serving international markets across Asia, Africa, and the Middle East.

The company produces over 300 registered products, spanning antibiotics, antiparasitic agents, vaccines, vitamin supplements, and disinfectants, with manufacturing processes adhering to GMP-WHO standards.

Product and Service Offerings

HANVET offers a wide range of veterinary solutions categorized as follows:

• Antibiotics & Antibacterials:

  • Amoxyclav: Broad-spectrum beta-lactam antibiotic.
  • Enrofloxacin: Fluoroquinolone for respiratory and intestinal infections in poultry and swine.

• Parasitic Control Products:

  • Ivermectin: Injectable antiparasitic targeting both endo- and ectoparasites.
  • Albendazole: Oral broad-spectrum anthelmintic.

• Vaccines:

  • Avian Influenza Vaccine: For H5N1 prevention in poultry.
  • Foot-and-Mouth Disease (FMD) Vaccine: Targeting livestock immunity.
  • Newcastle Disease and Gumboro Vaccines: Widely adopted in poultry farms across Southeast Asia.

• Vitamins and Nutritional Premixes:

  • Multivitamin Supplements: Liquid and powder formulations to boost growth and immunity.
  • Mineral Premixes: For calcium, phosphorus, and trace element supplementation.

• Antiseptics & Hygiene Solutions:

  • Han-Iodine: Broad-spectrum iodine-based disinfectant.
  • Han-San: Fast-acting sanitizer for livestock housing and hatcheries.

HANVET supports its product lines with veterinary training, farm-level diagnostics, and formulation services.

Specialization and Unique Selling Proposition

HANVET’s competitive edge lies in its diverse product range, in-house vaccine R&D, and strong regional market presence:

• In-House Vaccine Production: One of the few Vietnamese companies with capability to produce inactivated and live vaccines for multiple species.
• Field-Based Efficacy Trials: Products tested in real-farm environments before market release.
• GMP-WHO Certified Plants: Three modern facilities including a vaccine-specific plant with ISO 17025-accredited QC labs.
• Affordable Solutions: Competitive pricing for developing and emerging markets without compromising quality.

This blend of science, scale, and accessibility positions HANVET as a vital contributor to food safety and animal welfare.

Financial Performance

As a Joint Stock Company with decades of legacy, HANVET holds a dominant share of the domestic veterinary medicine market in Vietnam:

• Estimated Annual Revenue: USD 20–25 million (2022)
• Domestic Market Share (Vietnam): Approx. 20% in veterinary pharmaceuticals
• Exports: Contribute over 30% of revenue, growing at ~15% CAGR
• Production Capacity:
  • Tablets & Powders: 1,500 tons/year
  • Injectable Solutions: 60 million vials/year
  • Vaccines: 300 million doses/year

Strong performance is driven by increased demand for biosecurity and disease prevention in regional livestock farming.

Shipment Records

According to trade data from Volza and customs databases:

• Annual Shipments: 500–600 international consignments
• Top Export Markets: Myanmar, Bangladesh, Egypt, Sudan, Nigeria, and Cambodia
• Primary Exported Products: Vaccines (FMD, ND), Amoxyclav, Han-Iodine, and vitamin premixes
• Logistics Capabilities: Centralized warehousing in Hanoi with regional export partnerships

HANVET has secured export approvals from over 15 national regulatory authorities, with product registration active in 20+ countries.

Target Market

HANVET’s products are used by a wide variety of clients including:

• Livestock and poultry farmers
• Feed manufacturers and integrators
• Veterinary clinics and pharmacies
• Government animal health programs
• Distributors and NGOs supporting livestock development

The company serves both high-density industrial farms and smallholder producers with scalable, reliable veterinary solutions.

Capabilities

• Research & Development: 50+ in-house scientists including virologists, microbiologists, and formulation chemists
• Manufacturing Infrastructure:
  • Dedicated vaccine plant with biosafety protocols
  • Antibiotic and vitamin production lines with automated filling and packaging
• Quality Assurance:
  • ISO 17025-certified quality control lab
  • Preclinical and clinical efficacy evaluations
• Training & Outreach:
  • On-farm diagnostic programs and veterinary workshops
  • Educational partnerships with veterinary universities

HANVET’s technical depth and field presence reinforce its position as a knowledge partner and supplier.

Certifications and Compliance

HANVET adheres to international quality and safety standards:

• GMP-WHO Certification for all production facilities
• ISO 9001:2015 and ISO 17025:2017 for quality and lab management
• Veterinary Drug Manufacturer License from Vietnam’s Ministry of Agriculture and Rural Development
• Product registration in ASEAN, Middle East, and African markets

All products undergo rigorous testing for stability, efficacy, and safety before release.

Customer Testimonials

“HANVET’s vaccines have consistently delivered strong immunity across our poultry flocks. Their support during disease outbreaks has been exceptional.”
— Tran V., Poultry Integrator, Vietnam

“We rely on HANVET’s multivitamin and parasitic control range across our farms in Sudan. Excellent product consistency and fair pricing.”
— Ahmed M., Livestock Exporter, Sudan

Major Achievements

• National Leader: Among Vietnam’s top three veterinary pharmaceutical manufacturers
• Vaccine Breakthroughs: Developed inactivated Avian Influenza and FMD vaccines domestically
• Global Expansion: Registered products in 20+ countries with active distributor networks
• Government Contracts: Supplier to national animal disease control programs in Vietnam
• Innovation Milestone: Launch of thermotolerant vaccines suitable for tropical markets

Pharmaceutical And Veterinary Material JSC (HANVET) continues to advance veterinary medicine through innovation, reliability, and accessibility—serving both domestic and global markets in their mission to protect animal health and support sustainable livestock development.